Sergey Lukyanov
Overview
Explore the profile of Sergey Lukyanov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
5548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Britanova O, Lupyr K, Staroverov D, Shagina I, Aleksandrov A, Ustyugov Y, et al.
Nat Med
. 2023 Oct;
29(11):2731-2736.
PMID: 37872223
Autoimmunity is intrinsically driven by memory T and B cell clones inappropriately targeted at self-antigens. Selective depletion or suppression of self-reactive T cells remains a holy grail of autoimmune therapy,...
2.
Komech E, Koltakova A, Barinova A, Minervina A, Salnikova M, Shmidt E, et al.
Front Immunol
. 2022 Nov;
13:973243.
PMID: 36325356
Spondyloarthritis (SpA) comprises a number of inflammatory rheumatic diseases with overlapping clinical manifestations. Strong association with several HLA-I alleles and T cell infiltration into an inflamed joint suggest involvement of...
3.
Goncharov M, Bryushkova E, Sharaev N, Skatova V, Baryshnikova A, Sharonov G, et al.
Elife
. 2022 Apr;
11.
PMID: 35377314
Adoptive cell transfer (ACT) is a promising approach to cancer immunotherapy, but its efficiency fundamentally depends on the extent of tumor-specific T cell enrichment within the graft. This can be...
4.
Kotlobay A, Sarkisyan K, Mokrushina Y, Marcet-Houben M, Serebrovskaya E, Markina N, et al.
Proc Natl Acad Sci U S A
. 2018 Nov;
115(50):12728-12732.
PMID: 30478037
Bioluminescence is found across the entire tree of life, conferring a spectacular set of visually oriented functions from attracting mates to scaring off predators. Half a dozen different luciferins, molecules...
5.
Komech E, Pogorelyy M, Egorov E, Britanova O, Rebrikov D, Bochkova A, et al.
Rheumatology (Oxford)
. 2018 Feb;
57(6):1097-1104.
PMID: 29481668
Objective: The risk of AS is associated with genomic variants related to antigen presentation and specific cytokine signalling pathways, suggesting the involvement of cellular immunity in disease initiation/progression. The aim...
6.
Shagin D, Turchaninova M, Shagina I, Shugay M, Zaretsky A, Zueva O, et al.
BMC Genomics
. 2017 Jun;
18(1):440.
PMID: 28583065
Background: Recently we proposed efficient method to exclude undesirable primers at any stage of amplification reaction, here termed NOPE (NOnsense-mediated Primer Exclusion). According to this method, added oligonucleotide overlapping with...
7.
Shagin D, Shagina I, Zaretsky A, Barsova E, Kelmanson I, Lukyanov S, et al.
Sci Rep
. 2017 Jun;
7(1):2718.
PMID: 28578414
The accuracy with which DNA polymerase can replicate a template DNA sequence is an extremely important property that can vary by an order of magnitude from one enzyme to another....
8.
Kaskova Z, Dorr F, Petushkov V, Purtov K, Tsarkova A, Rodionova N, et al.
Sci Adv
. 2017 May;
3(4):e1602847.
PMID: 28508049
Bioluminescent fungi are spread throughout the globe, but details on their mechanism of light emission are still scarce. Usually, the process involves three key components: an oxidizable luciferin substrate, a...
9.
Shugay M, Zaretsky A, Shagin D, Shagina I, Volchenkov I, Shelenkov A, et al.
PLoS Comput Biol
. 2017 May;
13(5):e1005480.
PMID: 28475621
Unique molecular identifiers (UMIs) show outstanding performance in targeted high-throughput resequencing, being the most promising approach for the accurate identification of rare variants in complex DNA samples. This approach has...
10.
Britanova O, Shugay M, Merzlyak E, Staroverov D, Putintseva E, Turchaninova M, et al.
J Immunol
. 2016 May;
196(12):5005-13.
PMID: 27183615
The diversity, architecture, and dynamics of the TCR repertoire largely determine our ability to effectively withstand infections and malignancies with minimal mistargeting of immune responses. In this study, we have...